BioSeeker Group Information

Oncology moves fast. Knowing what changed is only the beginning. 1stOncology™ helps stakeholders in cancer drug development identify the developments that matter, understand their competitive relevance, and inform their next move. Our Signal Intelligence connects clinical, scientific, regulatory, and business developments across drugs, targets, tumors, and companies. Prioritized signals bring meaningful changes into focus. From pivotal trial results and emerging competitors to licensing deals and upcoming catalysts. Our hybrid AI approach combines AI-assisted analysis with oncology expertise and structured intelligence. The aim: faster discovery, relevant context, and a clear path back to the underlying evidence. With live dashboards, tailored alerts, and tools for exploring the oncology landscape, 1stOncology supports competitive intelligence, business development, and R&D teams as they investigate opportunities and track evolving risks. Developed by BioSeeker Group, 1stOncology is an award-winning oncology intelligence solution with roots in Stockholm and Boston. See what changed. Understand what matters. Inform your next move.